GRI Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
1.6M
-17.7%
2.0M
-24.8%
2.7M
-20.8%
3.4M
+16.2%
2.9M
R&D
407.0K
+12.7%
361.0K
-77.9%
1.6M
-7.8%
1.8M
-5.9%
1.9M
SG&A
1.2M
-24.4%
1.6M
+59.0%
1.0M
-35.3%
1.6M
+56.8%
1.0M
Operating Income
-1648000
+17.7%
-2003000
+24.8%
-2664000
+20.8%
-3365000
-16.2%
-2897000
EBITDA
-1648000
+17.7%
-2002000
+24.8%
-2663000
+20.8%
-3364000
-16.2%
-2896000
Net Income
-1643000
+17.8%
-1998000
+24.9%
-2659000
+20.8%
-3359000
-16.1%
-2892000
EPS (Basic)
$-0.91
+43.5%
$-1.61
$-1.28
+96.5%
$-36.72
EPS (Diluted)
$-0.91
+43.5%
$-1.61
$-1.28
+96.5%
$-36.72
Shares (Diluted)
1.8M
+45.4%
1.2M
2.6M
+3228.6%
78.8K
GRI Bio (GRI) — Financials